Document is current
Any future updates will be listed below
-
Authors
Langdahl, Bente L. https://orcid.org/0000-0002-8712-7199
Lorentzon, Mattias
Borgen, Tove T.
Bajtner, Estelle
Kaarill, Tanja
Alstad, Cecilie
Rieem Dun, Alexander
Konradsen, Mie Sisse
Liseth Hansen, Johan
Ström, Oskar
Tsitlakidis, Evangelos
Moayyeri, Alireza
-
Funding
Funding for this research was provided by:
UCB
Amgen
- License Information
-
More Information
Article History
Received: 18 April 2025
Accepted: 30 October 2025
First Online: 19 November 2025
Declarations
:
: All the results presented in this article are in aggregate form and no personally identifiable information was used for this study. For this type of study formal consent is not required.
: Bente L. Langdahl declares having received fees and honoraria for lectures and advice from Amgen, Astellas, Astra-Zeneca, Gedeon-Richter, Samsung-Bioepis, Mereo, Angitia and UCB. Mattias Lorentzon declares having received lecture fees from Amgen, Astellas, Lilly, Meda, Medison, Consilient Health and UCB in addition to consulting fees from Amgen, Medac AB, Pharmacosmos, Gedeon Richter, Parexel International, and UCB. Tove T. Borgen declares having received speaker fees from Amgen, Roche Diagnostics, Pharma Prim and UCB, and participation in the advisory board for UCB. Cecilie Alstad is a former employee and stockholder of UCB. Estelle Bajtner is an employee and stockholder of UCB. Alexander Rieem Dunn is a former employee of Quantify Research, a contract research organization that provides consultancy services to the pharmaceutical industry. Tanja Kaarill is an employee of UCB. Mie Sisse Konradsen is a former employee of Quantify Research, a contract research organization that provides consultancy services to the pharmaceutical industry. Evangelos Tsitlakidis is a Significance consultant for UCB. Johan Liseth Hansen is an employee of Quantify Research, a contract research organization that provides consultancy services to the pharmaceutical industry. Oskar Ström is an employee of Quantify Research, a contract research organization that provides consultancy services to the pharmaceutical industry. Ali Moayyeri is an employee and stockholder of UCB.
: Data used in this study cannot be shared freely as it is the property of the Danish data holders. Other parties can request the same data sources and content by submitting new data applications to the data holders. The terms for using the data are governed by data holder approval subject to data application.
